- Home
- BNGO vs MIRA Comparison
BNGO vs MIRA Comparison
Compare BNGO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- MIRA
- Stock Information
- Founded
- BNGO 2003
- MIRA 2020
- Country
- BNGO United States
- MIRA United States
- Employees
- BNGO N/A
- MIRA N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- MIRA Health Care
- Exchange
- BNGO Nasdaq
- MIRA Nasdaq
- Market Cap
- BNGO 24.3M
- MIRA 19.5M
- IPO Year
- BNGO 2018
- MIRA 2023
- Fundamental
- Price
- BNGO $3.39
- MIRA $1.54
- Analyst Decision
- BNGO Buy
- MIRA Strong Buy
- Analyst Count
- BNGO 5
- MIRA 2
- Target Price
- BNGO $7.33
- MIRA $14.00
- AVG Volume (30 Days)
- BNGO 82.4K
- MIRA 3.0M
- Earning Date
- BNGO 08-06-2025
- MIRA 08-12-2025
- Dividend Yield
- BNGO N/A
- MIRA N/A
- EPS Growth
- BNGO N/A
- MIRA N/A
- EPS
- BNGO N/A
- MIRA N/A
- Revenue
- BNGO $28,464,000.00
- MIRA N/A
- Revenue This Year
- BNGO N/A
- MIRA N/A
- Revenue Next Year
- BNGO $15.54
- MIRA N/A
- P/E Ratio
- BNGO N/A
- MIRA N/A
- Revenue Growth
- BNGO N/A
- MIRA N/A
- 52 Week Low
- BNGO $2.68
- MIRA $0.62
- 52 Week High
- BNGO $41.10
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- BNGO 46.44
- MIRA 69.70
- Support Level
- BNGO $3.22
- MIRA $1.07
- Resistance Level
- BNGO $3.43
- MIRA $1.39
- Average True Range (ATR)
- BNGO 0.14
- MIRA 0.13
- MACD
- BNGO 0.03
- MIRA 0.02
- Stochastic Oscillator
- BNGO 72.41
- MIRA 77.05
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.